Cefpirome

Revision as of 00:08, 23 December 2013 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cefpirome
File:Cefpirome.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H22N6O5S2
Molar mass514.58 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefpirome is a fourth-generation cephalosporin. Trade names include Cefrom, Keiten, Broact, Cefir. Cefpirome is considered highly active against Gram-negative bacteria, including Pseudomonas aeruginosa, and Gram-positive bacteria. It is marketed under the brand name of CEFROM by sanofi aventis group india .

Spectrum of Bacterial Susceptibility and Resistance

Currently, Bacteroides fragilis, Enterococci, Pseudomonas spp. and Staphylococci are resistant to Cefpirome Sulfate, and some Haemophilus spp. and Pneumococci have developed resistance to Cefpirome Sulfate to varying degrees.[1]

References

  1. "Cefpirome Sulfate spectrum of bacterial susceptibility and Resistance" (PDF). Retrieved 10 April 2012.